Intra-Cellular Therapies Inc.
News
Why Is Intra-Cellular (ITCI) Down 2.7% Since Last Earnings Report?
Zacks Investment Research A month has gone by since the last earnings report for Intra-Cellular Therapies (ITCI). Shares have lost about 2.7% in that time frame, underperforming the S&P 500.Will the recent negative trend...\n more…
Peaking Back In On Intra-Cellular Therapies
SeekingAlpha Peaking Back In On Intra-Cellular Therapies...\n more…
When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Breakeven?
Simply Wall St With the business potentially at an important milestone, we thought we'd take a closer look at Intra-Cellular...\n more…
Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
Globe Newswire NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...\n more…
Intra-Cellular Therapies Moves Up In Market Cap Rank, Passing Caesars Entertainment
The Online Investor In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Intra-Cellular Therapies Inc (ITCI) was identified as having a larger market cap than the smaller end of...\n more…
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Simply Wall St As you might know, Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) just kicked off its latest quarterly results with...\n more…